Characterization of a New Staphylococcus aureus Kayvirus Harboring a Lysin Active against Biofilms

Luís D R Melo1, Ana Brandão2, Ergun Akturk3

  • 1LIBRO-Laboratório de Investigação em Biofilmes Rosário Oliveira, Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4700-057, Braga, Portugal. lmelo@deb.uminho.pt.

Viruses
|April 13, 2018
PubMed

Insights

A novel bacteriophage, vB_SauM-LM12, and its endolysin show broad-spectrum activity against Staphylococcus aureus, including multidrug-resistant strains. These agents effectively reduce bacterial biofilms, offering potential for treating persistent infections.

Area of Science:

  • Microbiology
  • Bacteriophage Therapy
  • Antimicrobial Resistance

Background:

  • Staphylococcus aureus is a significant opportunistic pathogen causing biofilm-associated diseases and hospital-acquired infections.
  • The rise of multidrug-resistant strains necessitates alternative therapeutic strategies.
  • Bacteriophages and their endolysins have shown promise as anti-staphylococcal agents.

Purpose of the Study:

  • To characterize a novel bacteriophage, vB_SauM-LM12 (LM12), and its encoded endolysin.
  • To evaluate the efficacy of LM12 and its endolysin against Staphylococcus aureus biofilms.
  • To assess the safety profile of the bacteriophage by analyzing its genome.

Main Methods:

  • Isolation and characterization of bacteriophage vB_SauM-LM12.
  • Genome sequencing and bioinformatics analysis of LM12.
  • In vitro antibiofilm assays using LM12 and its purified endolysin.
  • Evaluation of endolysin activity against different bacterial growth phases and biofilm structures.

Main Results:

  • LM12 exhibits a broad host range, active against over 90% of tested S. aureus strains, including methicillin-resistant S. aureus (MRSA).
  • The LM12 genome (143,625 bp dsDNA) lacks genes for virulence factors, toxins, or antibiotic resistance.
  • Both LM12 and its endolysin significantly reduced viable bacterial cells and biofilm biomass, with the endolysin showing higher efficacy against planktonic and stationary-phase cells.

Conclusions:

  • Bacteriophage LM12 and its endolysin possess potent antimicrobial and antibiofilm activities against Staphylococcus aureus.
  • The broad host range and safety profile of LM12 suggest its potential as a therapeutic agent.
  • Further investigation into the application of LM12 and its endolysin for treating S. aureus biofilm infections is warranted.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.5K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.1K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.9K
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.2K